How muscle loss affects disease course in GI cancers
Part of Brain & nervous system, Cancer, Digestive system clinical trials.
This study looks at how loss of muscle mass (sarcopenia) affects the course of illness in people with gastrointestinal cancers, liver cirrhosis, or those in the ICU. It will help doctors better understand and treat muscle wasting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a gastrointestinal tumor (such as stomach, colon, or pancreatic cancer), or liver cirrhosis, or be in the intensive care unit
- You need to be able to give your own consent to participate
- You cannot have a muscle disease you were born with (like muscular dystrophy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
This study looks at muscle loss (sarcopenia) in people with lung cancer who are about to have surgery. It uses a CT or MRI scan to check your muscle health, which may help doctors better plan your care.
This study uses ultrasound to measure muscle mass in people with cirrhosis. It aims to understand muscle changes and their link to health outcomes.
This study checks for muscle loss (sarcopenia) in ICU patients who need a breathing machine (mechanical ventilation). It aims to track how muscle health changes during hospital stay.
This trial looks at muscle loss (called sarcopenia) in people with colon cancer to test an intervention that may help strength or recovery. If you’re age 70 or older and meet the cancer and health requirements, you may be able to take part.
This study looks at the gut microbiome (the helpful bacteria in your gut) and muscle loss (sarcopenia) in people with liver cirrhosis. It may help researchers understand what changes in the gut and body can go along with getting weaker, so better treatments can be developed.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.